Explore the words cloud of the MAGICBULLET project. It provides you a very rough idea of what is the project "MAGICBULLET" about.
The following table provides information about the project.
Coordinator |
UNIVERSITAET BIELEFELD
Organization address contact info |
Coordinator Country | Germany [DE] |
Project website | http://www.magicbullet.de |
Total cost | 3˙746˙420 € |
EC max contribution | 3˙746˙420 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2014 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2015 |
Duration (year-month-day) | from 2015-01-01 to 2018-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITAET BIELEFELD | DE (BIELEFELD) | coordinator | 498˙432.00 |
2 | HELSINGIN YLIOPISTO | FI (HELSINGIN YLIOPISTO) | participant | 538˙290.00 |
3 | UNIVERSITA DEGLI STUDI DELL'INSUBRIA | IT (VARESE) | participant | 516˙122.00 |
4 | UNIVERSITA DEGLI STUDI DI MILANO | IT (MILANO) | participant | 516˙122.00 |
5 | HEIDELBERG PHARMA RESEARCH GMBH | DE (LADENBURG) | participant | 498˙432.00 |
6 | EOTVOS LORAND TUDOMANYEGYETEM | HU (BUDAPEST) | participant | 447˙827.00 |
7 | EXIRIS SRL | IT (ROMA) | participant | 258˙061.00 |
8 | UNIVERSITAET ZU KOELN | DE (KOELN) | participant | 249˙216.00 |
9 | Orszagos Onkologiai Intezet | HU (Budapest) | participant | 223˙913.00 |
10 | Bayer Pharma AG | DE (Berlin) | partner | 0.00 |
11 | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. | DE (MUNCHEN) | partner | 0.00 |
12 | FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG | DE (ERLANGEN) | partner | 0.00 |
13 | IRBM SCIENCE PARK SPA | IT (POMEZIA RM) | partner | 0.00 |
14 | Kineto Lab Ltd. | HU (Budapest) | partner | 0.00 |
Many tumor cells are characterized by the overexpression of certain antigens. Molecules that specifically recognize these structures are suitable as homing devices in tumor therapy. Conjugates of anticancer drugs with such a delivery vector targeting tumors would be a “magic bullet” according to the Nobel laureate Paul Ehrlich. Three antibody-drug conjugates (ADC) have already been approved for anticancer therapy. However, ADC have e.g. limitations with respect to tumor penetration, high manufacturing costs, and require challenging conjugation chemistry. Peptide-drug conjugates can have a high drug loading, easily penetrate tissue, and can be easily prepared in a homogenous form with straightforward and well-defined conjugation chemistry. The ETN MAGICBULLET will focus on chemistry-driven approaches toward conjugates between peptides (delivery vectors) that recognize tumors and anticancer drugs (payloads or warheads) in order to selectively fight cancer, a topic with a high demand of research activities. The ETN will develop and validate an array of new peptide-drug conjugates combining either known tumor-specific peptides or newly discovered tumor-homing peptides with potent cytotoxic drugs. The tumor-selective peptides are designed for cellular uptake mediated either by endocytosis or by cell-penetrating peptides. The consortium of the ETN MAGICBULLET covers tumor biology, biochemistry, pharmacology, synthetic chemistry, medicinal chemistry, spectroscopy, conformational analysis, and computational chemistry. The training program focuses on multidisciplinary research to explore and validate molecular targets for innovative treatment or investigations on the molecular mechanisms in organ-specific metastatic growth processes. It aims at scientific multilingualism and relies e.g. on concerted learning, a combination of introductory training, hands-on learning “on the bench”, teaching by peers, and training in additional skills.
Summer School | Other | 2019-07-23 08:35:18 |
Feature article on Peptide-Drug Conjugates | Documents, reports | 2019-07-23 08:35:18 |
Videos | Websites, patent fillings, videos etc. | 2019-07-23 08:35:18 |
Special issue on Peptide-Drug Conjugates | Documents, reports | 2019-07-23 08:35:18 |
International Network Symposium | Other | 2019-07-23 08:35:18 |
Completion of Website | Websites, patent fillings, videos etc. | 2019-07-23 08:35:17 |
Take a look to the deliverables list in detail: detailed list of MAGICBULLET deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Eduard Figueras, Adina Borbély, Mohamed Ismail, Marcel Frese, Norbert Sewald Novel unit B cryptophycin analogues as payloads for targeted therapy published pages: 1281-1286, ISSN: 1860-5397, DOI: 10.3762/bjoc.14.109 |
Beilstein Journal of Organic Chemistry 14 | 2019-07-23 |
2018 |
Andrea Angelo Pierluigi Tripodi, Szilárd Tóth, Kata Nóra Enyedi, Gitta Schlosser, Gergely Szakács, Gábor Mező Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property published pages: 911-918, ISSN: 1860-5397, DOI: 10.3762/bjoc.14.78 |
Beilstein Journal of Organic Chemistry 14 | 2019-07-23 |
2018 |
Lizeth Bodero, Paula López Rivas, Barbara Korsak, Torsten Hechler, Andreas Pahl, Christoph Müller, Daniela Arosio, Luca Pignataro, Cesare Gennari, Umberto Piarulli Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting published pages: 407-415, ISSN: 1860-5397, DOI: 10.3762/bjoc.14.29 |
Beilstein Journal of Organic Chemistry 14 | 2019-07-23 |
2018 |
Samuele Cazzamalli, Eduard Figueras, Lilla Pethő, Adina Borbély, Christian Steinkühler, Dario Neri, Norbert Sewald In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas published pages: 14726-14731, ISSN: 2470-1343, DOI: 10.1021/acsomega.8b02350 |
ACS Omega 3/11 | 2019-07-23 |
2017 |
Christine Weiss, Eduard Figueras, Adina N. Borbely, Norbert Sewald Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting published pages: 514-531, ISSN: 1075-2617, DOI: 10.1002/psc.3015 |
Journal of Peptide Science 23/7-8 | 2019-07-23 |
2018 |
Sabine Schuster, Beáta Biri-Kovács, Bálint Szeder, László Buday, János Gardi, Zsuzsanna Szabó, Gábor Halmos, Gábor Mező Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification published pages: 223, ISSN: 1999-4923, DOI: 10.3390/pharmaceutics10040223 |
Pharmaceutics 10/4 | 2019-07-23 |
2018 |
Paula López Rivas, Ivan Ranđelović, André Raposo Moreira Dias, Arianna Pina, Daniela Arosio, József Tóvári, Gábor Mező, Alberto Dal Corso, Luca Pignataro, Cesare Gennari Synthesis and Biological Evaluation of Paclitaxel Conjugates Involving Linkers Cleavable by Lysosomal Enzymes and α V β 3 -Integrin Ligands for Tumor Targeting published pages: 2902-2909, ISSN: 1434-193X, DOI: 10.1002/ejoc.201800447 |
European Journal of Organic Chemistry 2018/23 | 2019-07-23 |
2017 |
Anja Gronewold, Mareike Horn, Ivan Ranđelović, Dr. József Tóvári, Sergio Muñoz Vázquez, Prof. Dr. Klaus Schomäcker, Prof. Dr. Ines Neundorf Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity published pages: 42–49, ISSN: 1860-7187, DOI: 10.1002/cmdc.201600498 |
ChemMedChem Januar 5, 2017, Volume 12, Issu | 2019-07-23 |
2017 |
Simone Zanella, Simona Angerani, Arianna Pina, Paula López Rivas, Clelia Giannini, Silvia Panzeri, Daniela Arosio, Michele Caruso, Fabio Gasparri, Ivan Fraietta, Clara Albanese, Aurelio Marsiglio, Luca Pignataro, Laura Belvisi, Umberto Piarulli, Cesare Gennari Tumor Targeting with an iso DGR-Drug Conjugate published pages: 7910-7914, ISSN: 0947-6539, DOI: 10.1002/chem.201701844 |
Chemistry - A European Journal 23/33 | 2019-07-23 |
2017 |
André Raposo Moreira Dias, Arianna Pina, Alberto Dal Corso, Daniela Arosio, Laura Belvisi, Luca Pignataro, Michele Caruso, Cesare Gennari Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin α V β 3 published pages: 14410-14415, ISSN: 0947-6539, DOI: 10.1002/chem.201703093 |
Chemistry - A European Journal 23/58 | 2019-07-23 |
2018 |
Sabine Schuster, Beáta Biri-Kovács, Bálint Szeder, Viktor Farkas, László Buday, Zsuzsanna Szabó, Gábor Halmos, Gábor Mező Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery published pages: 756-771, ISSN: 1860-5397, DOI: 10.3762/bjoc.14.64 |
Beilstein Journal of Organic Chemistry 14 | 2019-07-23 |
2017 |
Lucia Feni, M. Omrane, Moritz Fischer, Boris Zlatopolskiy, Bernd Neumaier, Ines Neundorf Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging published pages: 99, ISSN: 1424-8247, DOI: 10.3390/ph10040099 |
Pharmaceuticals 10/4 | 2019-07-23 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAGICBULLET" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MAGICBULLET" are provided by the European Opendata Portal: CORDIS opendata.